Last reviewed · How we verify
Autologous Adipose Derieved MSCs
At a glance
| Generic name | Autologous Adipose Derieved MSCs |
|---|---|
| Sponsor | Kasiak Research Pvt. Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous Adipose Derieved MSCs CI brief — competitive landscape report
- Autologous Adipose Derieved MSCs updates RSS · CI watch RSS
- Kasiak Research Pvt. Ltd. portfolio CI